According to Latest Research by Market IntelliX, the global market for Live and Attenuated Vaccine should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

China Live and Attenuated Vaccine market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

The United States Live and Attenuated Vaccine market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

In terms of type, Pediatric Vaccine segment holds a share about % in 2023 and will reach % in 2030; while in terms of application, Hospitals has a share approximately % in 2023 and will grow at a CAGR % during 2023 and 2030.

The global key manufacturers of Live and Attenuated Vaccine include GlaxoSmithKline, Merck & Co., Pfizer, Inc, Astellas Pharma Inc, Johnson & Johnson, CSL Limited, Emergent BioSolutions, Inc., MedImmune, LLC and Sanofi, etc. In 2023, the global top five players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive study of the global market for Live and Attenuated Vaccine. Report Highlights:

(1) Global Live and Attenuated Vaccine market size (sales volume & revenue), history data from 2019-2024 and forecast data from 2024 to 2030.

(2) Global Live and Attenuated Vaccine market competitive situation, sales, revenue, price and market share, from 2019 to 2024.

(3) China Live and Attenuated Vaccine market competitive situation, sales, revenue, price and market share, from 2019 to 2024.

(4) Global Live and Attenuated Vaccine segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Live and Attenuated Vaccine segment by type and by application and regional segment by type and by application.

(6) Global major production regions of Live and Attenuated Vaccine, capacity, production and trends.

(7) Live and Attenuated Vaccine industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Pediatric Vaccine

Adult Vaccines

Market segment by application, can be divided into

Hospitals

Clinics

Diagnostic Centers

Research Institute

Others

Market segment by players, this report covers

GlaxoSmithKline

Merck & Co.

Pfizer, Inc

Astellas Pharma Inc

Johnson & Johnson

CSL Limited

Emergent BioSolutions, Inc.

MedImmune, LLC

Sanofi

Serum Institute

1 Market Overview

1.1 Live and Attenuated Vaccine Definition

1.2 Global Live and Attenuated Vaccine Market Size and Forecast

1.2.1 By Revenue, Global Live and Attenuated Vaccine Market Size, 2019-2030

1.2.2 By Sales Volume, Global Live and Attenuated Vaccine Market Size, 2019-2030

1.2.3 Global Live and Attenuated Vaccine Price Trend, 2019-2030

1.3 China Live and Attenuated Vaccine Market Size and Forecast

1.3.1 By Revenue, China Live and Attenuated Vaccine Market Size, 2019-2030

1.3.2 By Sales Volume, China Live and Attenuated Vaccine Market Size, 2019-2030

1.3.3 China Live and Attenuated Vaccine Price Trend, 2019-2030

1.4 China Percentage in Global Market

1.4.1 By Revenue, China Live and Attenuated Vaccine Share in Global Market, 2019-2030

1.4.2 By Sales Volume, China Live and Attenuated Vaccine Share in Global Market, 2019-2030

1.4.3 Live and Attenuated Vaccine Market Size: China VS Global, 2019-2030

1.5 Live and Attenuated Vaccine Market Dynamics

1.5.1 Live and Attenuated Vaccine Market Drivers

1.5.2 Live and Attenuated Vaccine Market Restraints

1.5.3 Live and Attenuated Vaccine Industry Trends

1.5.4 Live and Attenuated Vaccine Industry Policy

2 Global Competitive Landscape by Company

2.1 Global Live and Attenuated Vaccine Revenue by Company, 2019-2024

2.2 Global Live and Attenuated Vaccine Sales Volume by Company, 2019-2024

2.3 Global Live and Attenuated Vaccine Price by Company, 2019-2024

2.4 Global Live and Attenuated Vaccine Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.5 Global Live and Attenuated Vaccine Concentration Ratio

2.6 Global Live and Attenuated Vaccine Mergers & Acquisitions, Expansion Plans

2.7 Global Live and Attenuated Vaccine Manufacturers Product Type

3 China Competitive Landscape by Company

3.1 China Live and Attenuated Vaccine Revenue by Company, 2019-2024

3.2 China Live and Attenuated Vaccine Sales Volume by Company, 2019-2024

3.3 China Live and Attenuated Vaccine Live and Attenuated Vaccine Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.4 China Live and Attenuated Vaccine Market, Sales Percentage of Local Players VS Foreign Players (2019-2024)

3.5 Chinese Local Players, Live and Attenuated Vaccine Domestic VS Export

3.6 China Market, Live and Attenuated Vaccine Import & Export

3.6.1 China Market, Live and Attenuated Vaccine Import & Export, 2019-2030

3.6.2 China Live and Attenuated Vaccine Import & Export Trends

3.6.3 Main Sources of China Live and Attenuated Vaccine Import

3.6.4 Export Destination of China Live and Attenuated Vaccine

4 Live and Attenuated Vaccine Production by Region

4.1 Global Live and Attenuated Vaccine Capacity, Production and Capacity Utilization, 2019-2030

4.2 Global Geographic Distribution of Live and Attenuated Vaccine Manufacturers

4.3 Global Major Manufacturers, Live and Attenuated Vaccine Capacity Expansion and Future Plans

4.4 Global Live and Attenuated Vaccine Capacity by Region

4.5 Global Live and Attenuated Vaccine Production by Region

4.5.1 Global Live and Attenuated Vaccine Production & Forecast by Region, 2019 VS 2024 VS 2030

4.5.2 Global Live and Attenuated Vaccine Production by Region, 2019-2024

4.5.3 Global Live and Attenuated Vaccine Production Market Share & Forecast by Region, 2019-2030

5 Industry Chain Analysis

5.1 Live and Attenuated Vaccine Industry Chain

5.2 Live and Attenuated Vaccine Upstream Analysis

5.2.1 Live and Attenuated Vaccine Core Raw Materials

5.2.2 Main Manufacturers of Live and Attenuated Vaccine Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 Live and Attenuated Vaccine Production Mode

5.6 Live and Attenuated Vaccine Procurement Model

5.7 Live and Attenuated Vaccine Industry Sales Model and Sales Channels

5.7.1 Live and Attenuated Vaccine Sales Model

5.7.2 Live and Attenuated Vaccine Typical Distributors

6 Sights by Type

6.1 Live and Attenuated Vaccine Classification

6.1.1 Pediatric Vaccine

6.1.2 Adult Vaccines

6.2 By Type, Global Live and Attenuated Vaccine Market Size & CAGR, 2019 VS 2024 VS 2030

6.3 By Type, Global Live and Attenuated Vaccine Revenue, 2019-2030

6.4 By Type, Global Live and Attenuated Vaccine Sales Volume, 2019-2030

6.5 By Type, Global Live and Attenuated Vaccine Price, 2019-2030

7 Sights by Application

7.1 Live and Attenuated Vaccine Segment by Application

7.1.1 Hospitals

7.1.2 Clinics

7.1.3 Diagnostic Centers

7.1.4 Research Institute

7.1.5 Others

7.2 By Application, Global Live and Attenuated Vaccine Market Size & CAGR, 2019 VS 2024 VS 2030

7.3 By Application, Global Live and Attenuated Vaccine Revenue, 2019-2030

7.4 By Application, Global Live and Attenuated Vaccine Sales Volume, 2019-2030

7.5 By Application, Global Live and Attenuated Vaccine Price, 2019-2030

8 Sales Sights by Region

8.1 By Region, Global Live and Attenuated Vaccine Market Size, 2019 VS 2024 VS 2030

8.2 By Region, Global Live and Attenuated Vaccine Revenue, 2019-2030

8.3 By Region, Global Live and Attenuated Vaccine Sales Volume, 2019-2030

8.4 North America

8.4.1 North America Live and Attenuated Vaccine Market Size & Forecasts, 2019-2030

8.4.2 By Country, North America Live and Attenuated Vaccine Market Size Market Share

8.5 Europe

8.5.1 Europe Live and Attenuated Vaccine Market Size & Forecasts, 2019-2030

8.5.2 By Country, Europe Live and Attenuated Vaccine Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific Live and Attenuated Vaccine Market Size & Forecasts, 2019-2030

8.6.2 By Country/Region, Asia Pacific Live and Attenuated Vaccine Market Size Market Share

8.7 South America

8.7.1 South America Live and Attenuated Vaccine Market Size & Forecasts, 2019-2030

8.7.2 By Country, South America Live and Attenuated Vaccine Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global Live and Attenuated Vaccine Market Size & CAGR，2019 VS 2024 VS 2030

9.2 By Country, Global Live and Attenuated Vaccine Revenue, 2019-2030

9.3 By Country, Global Live and Attenuated Vaccine Sales Volume, 2019-2030

9.4 U.S.

9.4.1 U.S. Live and Attenuated Vaccine Market Size, 2019-2030

9.4.2 By Company, U.S. Live and Attenuated Vaccine Sales Volume Market Share, 2024

9.4.3 By Type, U.S. Live and Attenuated Vaccine Market Size, Share, 2024 VS 2030

9.4.4 By Application, U.S. Live and Attenuated Vaccine Market Size, Share, 2024 VS 2030

9.5 Europe

9.5.1 Europe Live and Attenuated Vaccine Market Size, 2019-2030

9.5.2 By Company, Europe Live and Attenuated Vaccine Sales Volume Market Share, 2024

9.5.3 By Type, Europe Live and Attenuated Vaccine Market Size, Share, 2024 VS 2030

9.5.4 By Application, Europe Live and Attenuated Vaccine Market Size, Share, 2024 VS 2030

9.6 China

9.6.1 China Live and Attenuated Vaccine Market Size, 2019-2030

9.6.2 By Company, China Live and Attenuated Vaccine Sales Volume Market Share, 2024

9.6.3 By Type, China Live and Attenuated Vaccine Market Size, Share, 2024 VS 2030

9.6.4 By Application, China Live and Attenuated Vaccine Market Size, Share, 2024 VS 2030

9.7 Japan

9.7.1 Japan Live and Attenuated Vaccine Market Size, 2019-2030

9.7.2 By Company, Japan Live and Attenuated Vaccine Sales Volume Market Share, 2024

9.7.3 By Type, Japan Live and Attenuated Vaccine Market Size, Share, 2024 VS 2030

9.7.4 By Application, Japan Live and Attenuated Vaccine Market Size, Share, 2024 VS 2030

9.8 South Korea

9.8.1 South Korea Live and Attenuated Vaccine Market Size, 2019-2030

9.8.2 By Company, South Korea Live and Attenuated Vaccine Sales Volume Market Share, 2024

9.8.3 By Type, South Korea Live and Attenuated Vaccine Market Size, Share, 2024 VS 2030

9.8.4 By Application, South Korea Live and Attenuated Vaccine Market Size, Share, 2024 VS 2030

9.9 Southeast Asia

9.9.1 Southeast Asia Live and Attenuated Vaccine Market Size, 2019-2030

9.9.2 By Company, Southeast Asia Live and Attenuated Vaccine Sales Volume Market Share, 2024

9.9.3 By Type, Southeast Asia Live and Attenuated Vaccine Market Size, Share, 2024 VS 2030

9.9.4 By Application, Southeast Asia Live and Attenuated Vaccine Market Size, Share, 2024 VS 2030

9.10 India

9.10.1 India Live and Attenuated Vaccine Market Size, 2019-2030

9.10.2 By Company, India Live and Attenuated Vaccine Sales Volume Market Share, 2024

9.10.3 By Type, India Live and Attenuated Vaccine Market Size, Share, 2024 VS 2030

9.10.4 By Application, India Live and Attenuated Vaccine Market Size, Share, 2024 VS 2030

9.11 Middle East & Asia

9.11.1 Middle East & Asia Live and Attenuated Vaccine Market Size, 2019-2030

9.11.2 By Company, Middle East & Asia Live and Attenuated Vaccine Sales Volume Market Share, 2024

9.11.3 By Type, Middle East & Asia Live and Attenuated Vaccine Market Size, Share, 2024 VS 2030

9.11.4 By Application, Middle East & Asia Live and Attenuated Vaccine Market Size, Share, 2024 VS 2030

10 Manufacturers Profile

10.1 GlaxoSmithKline

10.1.1 GlaxoSmithKline Company Information, Head Office, Market Area and Industry Position

10.1.2 GlaxoSmithKline Live and Attenuated Vaccine Models, Specifications and Application

10.1.3 GlaxoSmithKline Live and Attenuated Vaccine Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.1.4 GlaxoSmithKline Company Profile and Main Business

10.1.5 GlaxoSmithKline Recent Developments

10.2 Merck & Co.

10.2.1 Merck & Co. Company Information, Head Office, Market Area and Industry Position

10.2.2 Merck & Co. Live and Attenuated Vaccine Models, Specifications and Application

10.2.3 Merck & Co. Live and Attenuated Vaccine Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.2.4 Merck & Co. Company Profile and Main Business

10.2.5 Merck & Co. Recent Developments

10.3 Pfizer, Inc

10.3.1 Pfizer, Inc Company Information, Head Office, Market Area and Industry Position

10.3.2 Pfizer, Inc Live and Attenuated Vaccine Models, Specifications and Application

10.3.3 Pfizer, Inc Live and Attenuated Vaccine Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.3.4 Pfizer, Inc Company Profile and Main Business

10.3.5 Pfizer, Inc Recent Developments

10.4 Astellas Pharma Inc

10.4.1 Astellas Pharma Inc Company Information, Head Office, Market Area and Industry Position

10.4.2 Astellas Pharma Inc Live and Attenuated Vaccine Models, Specifications and Application

10.4.3 Astellas Pharma Inc Live and Attenuated Vaccine Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.4.4 Astellas Pharma Inc Company Profile and Main Business

10.4.5 Astellas Pharma Inc Recent Developments

10.5 Johnson & Johnson

10.5.1 Johnson & Johnson Company Information, Head Office, Market Area and Industry Position

10.5.2 Johnson & Johnson Live and Attenuated Vaccine Models, Specifications and Application

10.5.3 Johnson & Johnson Live and Attenuated Vaccine Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.5.4 Johnson & Johnson Company Profile and Main Business

10.5.5 Johnson & Johnson Recent Developments

10.6 CSL Limited

10.6.1 CSL Limited Company Information, Head Office, Market Area and Industry Position

10.6.2 CSL Limited Live and Attenuated Vaccine Models, Specifications and Application

10.6.3 CSL Limited Live and Attenuated Vaccine Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.6.4 CSL Limited Company Profile and Main Business

10.6.5 CSL Limited Recent Developments

10.7 Emergent BioSolutions, Inc.

10.7.1 Emergent BioSolutions, Inc. Company Information, Head Office, Market Area and Industry Position

10.7.2 Emergent BioSolutions, Inc. Live and Attenuated Vaccine Models, Specifications and Application

10.7.3 Emergent BioSolutions, Inc. Live and Attenuated Vaccine Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.7.4 Emergent BioSolutions, Inc. Company Profile and Main Business

10.7.5 Emergent BioSolutions, Inc. Recent Developments

10.8 MedImmune, LLC

10.8.1 MedImmune, LLC Company Information, Head Office, Market Area and Industry Position

10.8.2 MedImmune, LLC Live and Attenuated Vaccine Models, Specifications and Application

10.8.3 MedImmune, LLC Live and Attenuated Vaccine Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.8.4 MedImmune, LLC Company Profile and Main Business

10.8.5 MedImmune, LLC Recent Developments

10.9 Sanofi

10.9.1 Sanofi Company Information, Head Office, Market Area and Industry Position

10.9.2 Sanofi Live and Attenuated Vaccine Models, Specifications and Application

10.9.3 Sanofi Live and Attenuated Vaccine Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.9.4 Sanofi Company Profile and Main Business

10.9.5 Sanofi Recent Developments

10.10 Serum Institute

10.10.1 Serum Institute Company Information, Head Office, Market Area and Industry Position

10.10.2 Serum Institute Live and Attenuated Vaccine Models, Specifications and Application

10.10.3 Serum Institute Live and Attenuated Vaccine Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.10.4 Serum Institute Company Profile and Main Business

10.10.5 Serum Institute Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. Live and Attenuated Vaccine Market Size & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. Live and Attenuated Vaccine Market Restraints

Table 3. Live and Attenuated Vaccine Market Trends

Table 4. Live and Attenuated Vaccine Industry Policy

Table 5. Global Live and Attenuated Vaccine Revenue by Company, 2019-2024, US$ million

Table 6. Global Live and Attenuated Vaccine Revenue Market Share by Company, 2019-2024

Table 7. Global Live and Attenuated Vaccine Sales Volume by Company, 2019-2024, (K Units)

Table 8. Global Live and Attenuated Vaccine Sales Volume Market Share by Company, 2019-2024

Table 9. Global Live and Attenuated Vaccine Price by Company, 2019-2024, (US$/Unit)

Table 10. Global Live and Attenuated Vaccine Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Live and Attenuated Vaccine Mergers & Acquisitions, Expansion Plans

Table 12. Global Live and Attenuated Vaccine Manufacturers Product Type

Table 13. China Live and Attenuated Vaccine Revenue by Company, 2019-2024, US$ million

Table 14. China Live and Attenuated Vaccine Revenue Market Share by Company, 2019-2024

Table 15. China Live and Attenuated Vaccine Sales Volume by Company, 2019-2024, (K Units)

Table 16. China Live and Attenuated Vaccine Sales Volume Market Share by Company, 2019-2024

Table 17. China Market, Live and Attenuated Vaccine Production, Sales, Import and Export, 2019-2030, (K Units)

Table 18. China Live and Attenuated Vaccine Import & Export Trends

Table 19. Main Sources of China Live and Attenuated Vaccine Import

Table 20. Export Destination of China Live and Attenuated Vaccine

Table 21. Global Headquarters and Manufacturing Base of Live and Attenuated Vaccine Manufacturers

Table 22. Global Major Manufacturers, Live and Attenuated Vaccine Capacity Expansion and Future Plans

Table 23. Global Live and Attenuated Vaccine Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)

Table 24. Global Live and Attenuated Vaccine Production by Region, 2019-2024, (K Units)

Table 25. Global Live and Attenuated Vaccine Production Forecast by Region, 2024-2030, (K Units)

Table 26. Global Key Players of Live and Attenuated Vaccine Upstream (Raw Materials)

Table 27. Global Live and Attenuated Vaccine Typical Customers

Table 28. Live and Attenuated Vaccine Typical Distributors

Table 29. By Type, Global Live and Attenuated Vaccine Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 30. By Application, Global Live and Attenuated Vaccine Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 31. By Region, Global Live and Attenuated Vaccine Market Size, 2019 VS 2024 VS 2030, US$ Million

Table 32. By Region, Global Live and Attenuated Vaccine Revenue, 2019-2030, US$ Million

Table 33. By Region, Global Live and Attenuated Vaccine Sales Volume, 2019-2030, (K Units)

Table 34. By Country, Global Live and Attenuated Vaccine Revenue & CAGR，2019 VS 2024 VS 2030, US$ Million

Table 35. By Country, Global Live and Attenuated Vaccine Revenue, 2019-2030, US$ Million

Table 36. By Country, Global Live and Attenuated Vaccine Revenue Market Share, 2019-2030

Table 37. By Country, Global Live and Attenuated Vaccine Sales Volume, 2019-2030, (K Units)

Table 38. By Country, Global Live and Attenuated Vaccine Sales Volume Market Share, 2019-2030

Table 39. GlaxoSmithKline Company Information, Head Office, Market Area and Industry Position

Table 40. GlaxoSmithKline Live and Attenuated Vaccine Models, Specifications and Application

Table 41. GlaxoSmithKline Live and Attenuated Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 42. GlaxoSmithKline Company Profile and Main Business

Table 43. GlaxoSmithKline Recent Developments

Table 44. Merck & Co. Company Information, Head Office, Market Area and Industry Position

Table 45. Merck & Co. Live and Attenuated Vaccine Models, Specifications and Application

Table 46. Merck & Co. Live and Attenuated Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 47. Merck & Co. Company Profile and Main Business

Table 48. Merck & Co. Recent Developments

Table 49. Pfizer, Inc Company Information, Head Office, Market Area and Industry Position

Table 50. Pfizer, Inc Live and Attenuated Vaccine Models, Specifications and Application

Table 51. Pfizer, Inc Live and Attenuated Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 52. Pfizer, Inc Company Profile and Main Business

Table 53. Pfizer, Inc Recent Developments

Table 54. Astellas Pharma Inc Company Information, Head Office, Market Area and Industry Position

Table 55. Astellas Pharma Inc Live and Attenuated Vaccine Models, Specifications and Application

Table 56. Astellas Pharma Inc Live and Attenuated Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 57. Astellas Pharma Inc Company Profile and Main Business

Table 58. Astellas Pharma Inc Recent Developments

Table 59. Johnson & Johnson Company Information, Head Office, Market Area and Industry Position

Table 60. Johnson & Johnson Live and Attenuated Vaccine Models, Specifications and Application

Table 61. Johnson & Johnson Live and Attenuated Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 62. Johnson & Johnson Company Profile and Main Business

Table 63. Johnson & Johnson Recent Developments

Table 64. CSL Limited Company Information, Head Office, Market Area and Industry Position

Table 65. CSL Limited Live and Attenuated Vaccine Models, Specifications and Application

Table 66. CSL Limited Live and Attenuated Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 67. CSL Limited Company Profile and Main Business

Table 68. CSL Limited Recent Developments

Table 69. Emergent BioSolutions, Inc. Company Information, Head Office, Market Area and Industry Position

Table 70. Emergent BioSolutions, Inc. Live and Attenuated Vaccine Models, Specifications and Application

Table 71. Emergent BioSolutions, Inc. Live and Attenuated Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 72. Emergent BioSolutions, Inc. Company Profile and Main Business

Table 73. Emergent BioSolutions, Inc. Recent Developments

Table 74. MedImmune, LLC Company Information, Head Office, Market Area and Industry Position

Table 75. MedImmune, LLC Live and Attenuated Vaccine Models, Specifications and Application

Table 76. MedImmune, LLC Live and Attenuated Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 77. MedImmune, LLC Company Profile and Main Business

Table 78. MedImmune, LLC Recent Developments

Table 79. Sanofi Company Information, Head Office, Market Area and Industry Position

Table 80. Sanofi Live and Attenuated Vaccine Models, Specifications and Application

Table 81. Sanofi Live and Attenuated Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 82. Sanofi Company Profile and Main Business

Table 83. Sanofi Recent Developments

Table 84. Serum Institute Company Information, Head Office, Market Area and Industry Position

Table 85. Serum Institute Live and Attenuated Vaccine Models, Specifications and Application

Table 86. Serum Institute Live and Attenuated Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 87. Serum Institute Company Profile and Main Business

Table 88. Serum Institute Recent Developments

List of Figure

Figure 1. Live and Attenuated Vaccine Picture

Figure 2. By Revenue, Global Live and Attenuated Vaccine Market Size and Forecast, 2019-2030, US$ Million

Figure 3. By Sales Volume, Global Live and Attenuated Vaccine Market Size and Forecast, 2019-2030, (K Units)

Figure 4. Global Live and Attenuated Vaccine Price Trend, 2019-2030, (US$/Unit)

Figure 5. By Revenue, China Live and Attenuated Vaccine Market Size and Forecast, 2019-2030, US$ million

Figure 6. By Sales Volume, China Live and Attenuated Vaccine Market Size and Forecast, 2019-2030, (K Units)

Figure 7. China Live and Attenuated Vaccine Price Trend, 2019-2030 (US$/Unit)

Figure 8. By Revenue, China Live and Attenuated Vaccine Share of Global Market, 2019-2030

Figure 9. By Sales Volume, China Live and Attenuated Vaccine Share of Global Market, 2019-2030

Figure 10. Global Live and Attenuated Vaccine Key Participants, Market Share, 2021 VS 2024 VS 2024

Figure 11. Global Live and Attenuated Vaccine Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2024

Figure 12. China Live and Attenuated Vaccine Key Participants, Market Share, 2021 VS 2024 VS 2024

Figure 13. China Live and Attenuated Vaccine Key Participants, Market Share, 2021 VS 2024 VS 2024

Figure 14. China Live and Attenuated Vaccine Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024

Figure 15. Chinese Local Players, Proportion of Live and Attenuated Vaccine Domestic VS Export, 2024

Figure 16. Global Live and Attenuated Vaccine Capacity, Production and Capacity Utilization, 2019-2030

Figure 17. Global Live and Attenuated Vaccine Capacity Market Share by Region, 2024 VS 2030

Figure 18. Global Live and Attenuated Vaccine Production Market Share & Forecast by Region, 2019-2030

Figure 19. Live and Attenuated Vaccine Industry Chain

Figure 20. Live and Attenuated Vaccine Procurement Model

Figure 21. Live and Attenuated Vaccine Sales Model

Figure 22. Live and Attenuated Vaccine Sales Channels, Direct Sales and Distribution

Figure 23. Pediatric Vaccine

Figure 24. Adult Vaccines

Figure 25. By Type, Global Live and Attenuated Vaccine Revenue, 2019-2030, US$ Million

Figure 26. By Type, Global Live and Attenuated Vaccine Revenue Market Share, 2019-2030

Figure 27. By Type, Global Live and Attenuated Vaccine Sales Volume, 2019-2030, (K Units)

Figure 28. By Type, Global Live and Attenuated Vaccine Sales Volume Market Share, 2019-2030

Figure 29. By Type, Global Live and Attenuated Vaccine Price, 2019-2030, (US$/Unit)

Figure 30. Hospitals

Figure 31. Clinics

Figure 32. Diagnostic Centers

Figure 33. Research Institute

Figure 34. Others

Figure 35. By Application, Global Live and Attenuated Vaccine Revenue, 2019-2030, US$ Million

Figure 36. By Application, Global Live and Attenuated Vaccine Revenue Market Share, 2019-2030

Figure 37. By Application, Global Live and Attenuated Vaccine Sales Volume, 2019-2030, (K Units)

Figure 38. By Application, Global Live and Attenuated Vaccine Sales Volume Market Share, 2019-2030

Figure 39. By Application, Global Live and Attenuated Vaccine Price, 2019-2030, (US$/Unit)

Figure 40. By Region, Global Live and Attenuated Vaccine Revenue Market Share, 2019-2030

Figure 41. By Region, Global Live and Attenuated Vaccine Sales Volume Market Share, 2019-2030

Figure 42. North America Live and Attenuated Vaccine Revenue & Forecasts, 2019-2030, US$ Million

Figure 43. By Country, North America Live and Attenuated Vaccine Revenue Market Share, 2024

Figure 44. Europe Live and Attenuated Vaccine Revenue & Forecasts, 2019-2030, US$ Million

Figure 45. By Country, Europe Live and Attenuated Vaccine Revenue Market Share, 2024

Figure 46. Asia Pacific Live and Attenuated Vaccine Revenue & Forecasts, 2019-2030, US$ Million

Figure 47. By Country/Region, Asia Pacific Live and Attenuated Vaccine Revenue Market Share, 2024

Figure 48. South America Live and Attenuated Vaccine Revenue & Forecasts, 2019-2030, US$ Million

Figure 49. By Country, South America Live and Attenuated Vaccine Revenue Market Share, 2024

Figure 50. Middle East & Africa Live and Attenuated Vaccine Revenue & Forecasts, 2019-2030, US$ Million

Figure 51. U.S. Live and Attenuated Vaccine Sales Volume, 2019-2030, (K Units)

Figure 52. By Company, U.S. Live and Attenuated Vaccine Market Share, 2024

Figure 53. By Type, U.S. Live and Attenuated Vaccine Sales Volume Market Share, 2024 VS 2030

Figure 54. By Application, U.S. Live and Attenuated Vaccine Sales Volume Market Share, 2024 VS 2030

Figure 55. Europe Live and Attenuated Vaccine Sales Volume, 2019-2030, (K Units)

Figure 56. By Company, Europe Live and Attenuated Vaccine Market Share, 2024

Figure 57. By Type, Europe Live and Attenuated Vaccine Sales Volume Market Share, 2024 VS 2030

Figure 58. By Application, Europe Live and Attenuated Vaccine Sales Volume Market Share, 2024 VS 2030

Figure 59. China Live and Attenuated Vaccine Sales Volume, 2019-2030, (K Units)

Figure 60. By Company, China Live and Attenuated Vaccine Market Share, 2024

Figure 61. By Type, China Live and Attenuated Vaccine Sales Volume Market Share, 2024 VS 2030

Figure 62. By Application, China Live and Attenuated Vaccine Sales Volume Market Share, 2024 VS 2030

Figure 63. Japan Live and Attenuated Vaccine Sales Volume, 2019-2030, (K Units)

Figure 64. By Company, Japan Live and Attenuated Vaccine Market Share, 2024

Figure 65. By Type, Japan Live and Attenuated Vaccine Sales Volume Market Share, 2024 VS 2030

Figure 66. By Application, Japan Live and Attenuated Vaccine Sales Volume Market Share, 2024 VS 2030

Figure 67. South Korea Live and Attenuated Vaccine Sales Volume, 2019-2030, (K Units)

Figure 68. By Company, South Korea Live and Attenuated Vaccine Market Share, 2024

Figure 69. By Type, South Korea Live and Attenuated Vaccine Sales Volume Market Share, 2024 VS 2030

Figure 70. By Application, South Korea Live and Attenuated Vaccine Sales Volume Market Share, 2024 VS 2030

Figure 71. Southeast Asia Live and Attenuated Vaccine Sales Volume, 2019-2030, (K Units)

Figure 72. By Company, Southeast Asia Live and Attenuated Vaccine Market Share, 2024

Figure 73. By Type, Southeast Asia Live and Attenuated Vaccine Sales Volume Market Share, 2024 VS 2030

Figure 74. By Application, Southeast Asia Live and Attenuated Vaccine Sales Volume Market Share, 2024 VS 2030

Figure 75. India Live and Attenuated Vaccine Sales Volume, 2019-2030, (K Units)

Figure 76. By Company, India Live and Attenuated Vaccine Market Share, 2024

Figure 77. By Type, India Live and Attenuated Vaccine Sales Volume Market Share, 2024 VS 2030

Figure 78. By Application, India Live and Attenuated Vaccine Sales Volume Market Share, 2024 VS 2030

Figure 79. Middle East & Asia Live and Attenuated Vaccine Sales Volume, 2019-2030, (K Units)

Figure 80. By Company, Middle East & Asia Live and Attenuated Vaccine Market Share, 2024

Figure 81. By Type, Middle East & Asia Live and Attenuated Vaccine Sales Volume Market Share, 2024 VS 2030

Figure 82. By Application, Middle East & Asia Live and Attenuated Vaccine Sales Volume Market Share, 2024 VS 2030

Figure 83. Research Methodology

Figure 84. Breakdown of Primary Interviews

Figure 85. Bottom-up Approaches

Figure 86. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)